Clinical, operational, and financial impact of an ultraviolet-C terminal disinfection intervention at a community hospital


      Hospital-acquired infections (HAIs) are a significant contributor to adverse patient outcomes and excess cost of inpatient care. Adjunct ultraviolet-C (UV-C) disinfection may be a viable strategy for reducing HAIs. This study aimed to measure the clinical, operational, and financial impact of a UV-C terminal disinfection intervention in a community hospital setting.


      Using a pre-post study design, we compared the HAI rates of 5 multidrug-resistant bacteria (Acinetobacter baumannii, Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and Pseudomonas aeruginosa) from 6 culture sites before and after a 12-month facility-wide UV-C intervention. To measure impact of UV-C disinfection on hospital operations, mean inpatient emergency room wait time was calculated. Finally, we conducted a cost saving analysis to evaluate the financial benefits of the intervention.


      Overall, 245 HAIs among 13,177 inpatients were observed during a 12-month intervention period, with an incidence rate of 3.94 per 1,000 patient days. This observed HAIs incidence was 19.2% lower than the preintervention period (4.87 vs 3.94 per 1,000 patient days; P = .006). The intervention did not adversely impact emergency department admissions (297.9 vs 296.2 minutes; P = .18) and generated a direct cost savings of $1,219,878 over a 12-month period.


      The UV-C disinfection intervention was associated with a statistically significant facility-wide reduction of multidrug-resistant HAIs and generated substantial direct cost savings without adversely impacting hospital operations.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Klevens R.M.
        • Edwards J.R.
        • Richards C.L.
        • Horan T.C.
        • Gaynes R.P.
        • Pollock D.A.
        • et al.
        Estimating health care associated infections and deaths in US hospitals, 2002.
        Public Health Rep. 2007; 122: 160-166
        • Rahmqvis M.
        • Samuelsson A.
        • Bastami S.
        • Rutberg H.
        Direct health care costs and length of hospital stay related to health care-acquired infections in adult patients based on point prevalence measurements.
        Am J Infect Control. 2016; 44: 500-506
        • Scott R.D.
        • National Center for Preparedness, Detection, and Control of Infectious Diseases (Centers for Disease Control and Prevention). Division of Healthcare Quality Promotion
        The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention.
        Centers for Disease Control (CDC), Atlanta (GA)2009
        • Magill S.S.
        • Edwards J.R.
        • Bamberg W.
        • Beldavs Z.G.
        • Dumyati G.
        • Kainer M.A.
        • et al.
        Multistate point-prevalence survey of health care–associated infections.
        N Engl J Med. 2014; 370: 1198-1208
        • Roberts R.
        • Scott D.
        • Cordell R.
        • Solomon S.
        • Steele L.
        • Kampe L.
        • et al.
        The use of economic modeling to determine the hospital costs associated with nosocomial infections.
        Clin Infect Dis. 2003; 36: 1424-1432
        • Murphy D.M.
        • Whiting J.
        Dispelling the myths: the true cost of healthcare-associated infections.
        Association for Professionals in Infection Control and Epidemiology (APIC), Washington (DC)2007
        • Weinstein R.A.
        Epidemiology and control of nosocomial infections in adult intensive care units.
        Am J Med. 1991; 91: 179S-184S
        • Weber D.J.
        • Rutala W.A.
        • Miller M.B.
        • Huslage K.
        • Sickbert-Bennett E.
        Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species.
        Am J Infect Control. 2010; 38: S25-S33
        • Kramer A.
        • Schwebke I.
        • Kampf G.
        How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.
        BMC Infect Dis. 2006; 6: 130
        • Carling P.C.
        • Parry M.M.
        • Rupp M.E.
        • Po J.L.
        • Dick B.
        • Von Beheren S.
        Improving cleaning of the environment surrounding patients in 36 acute care hospitals.
        Infect Control Hosp Epidemiol. 2008; 29: 1035-1041
        • Mitchell B.G.
        • Dancer S.J.
        • Anderson M.
        • Dehn E.
        Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis.
        J Hosp Infect. 2015; 91: 211-227
        • Carling P.C.
        • Bartley J.M.
        Evaluating hygienic cleaning in healthcare settings: what you do not know can harm your patients.
        Am J Infect Control. 2010; 38: S41-S50
        • Anderson D.
        • Chen L.
        • Weber D.
        • Moehring R.
        • Lewis S.
        • Triplett P.
        • et al.
        Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study.
        Lancet. 2017; 389: 805-814
        • Nerandzic M.M.
        • Cadnum J.L.
        • Pultz M.J.
        • Donskey C.J.
        Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms.
        BMC Infect Dis. 2010; 10: 197
        • Spencer M.
        • Vignari M.
        • Bryce E.
        • Johnson H.B.
        • Fauerbach L.
        • Denise Graham D.
        A model for choosing an automated ultraviolet-C disinfection system and building a case for the C-suite: two case reports.
        Am J Infect Control. 2017; 45: 288-292
        • Kowalski W.
        Ultraviolet germicidal irradiation handbook: UVGI for air and surface disinfection.
        Springer Science and Business Media, New York (NY)2010
        • Boyce J.M.
        • Havill N.L.
        • Moore B.A.
        Terminal decontamination of patient rooms using an automated mobile UV light unit.
        Infect Control Hosp Epidemiol. 2011; 32: 737-742
        • Napolitano N.A.
        • Mahapatra T.
        • Tang W.
        The effectiveness of UV-C radiation for facility-wide environmental disinfection to reduce health care–acquired infections.
        Am J Infect Control. 2015; 43: 1342-1346
        • Haas J.P.
        • Menz J.
        • Dusza S.
        • Montecalvo M.A.
        Implementation and impact of ultraviolet environmental disinfection in an acute care setting.
        Am J Infect Control. 2014; 42: 586-590
        • Miller R.
        • Simmons S.
        • Dale C.
        • Stachowiak J.
        • Stibich M.
        Utilization and impact of a pulsed-xenon ultraviolet room disinfection system and multidisciplinary care team on Clostridium difficile in a long-term acute care facility.
        Am J Infect Control. 2015; 43: 1350-1353
        • Levin J.
        • Riley L.S.
        • Parrish C.
        • English D.
        • Ahn S.
        The effect of portable pulsed xenon ultraviolet light after terminal cleaning on hospital-associated Clostridium difficile infection in a community hospital.
        Am J Infect Control. 2013; 41: 746-748
        • Nagaraja A.
        • Visintainer P.
        • Haas J.P.
        • Menz J.
        • Wormser G.P.
        • Montecalvo M.A.
        Clostridium difficile infections before and during use of ultraviolet disinfection.
        Am J Infect Control. 2015; 3: 940-945
        • Dancer S.
        Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.
        Clin Microbiol Rev. 2014; 27: 665-690
        • O'Brien J.
        • Lahue B.
        • Caro J.J.
        • Davidson D.
        The emerging infectious challenge of clostridium difficile–associated disease in Massachusetts hospitals: clinical and economic consequences.
        Infect Control Hosp Epidemiol. 2007; 28: 1219-1227
        • Healthcare Cost and Utilization Project (HCUP)
        Statistical brief #94: adult hospital stays with infections due to medical care, 2007.
        (Available from:) (Accessed September 1, 2010)
        • Stone P.W.
        • Larson E.
        • Kawar L.N.
        A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000.
        Am J Infect Control. 2002; 30: 145-152
        • U.S. Bureau of Labor Statistics
        Consumer price index.
        (Available from:) (Accessed May 1, 2018)